Delivery Order SPE2DB22D3401-SPE2DB25FT3WW
- Not listed
- The Defense Logistics Agency awarded a $1,007.15 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Varenicline 1 mg tablets (56-count packages). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count packaging) with a ceiling value of $1,720.86 under firm fixed price terms. The award, issued on December 12, 2025, with an ultimate completion date of December 15, 2025, represents a non-competitive delivery order with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,155.00 delivery order to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count packaging) with a firm fixed price structure. The order was competitively awarded without set-aside designation and is scheduled for completion by October 29, 2025. AmerisourceBergen will perform this delivery from its corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,996.74 to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets in a quantity of 56 units. The contract was awarded on May 22, 2025, with an ultimate completion date of May 23, 2025, and utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction under the company's existing federal contract vehicle, with performance to be fulfilled at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Varenicline 1 mg tablets (56-count packaging). This firm fixed-price contract, valued at $1,797.36, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The delivery order was...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Varenicline 1mg tablets (56-count packages) valued at $7,668.62, with completion scheduled for July 30, 2025. This competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. The award was issued under a non-set-aside competitive process, reflecting AmerisourceBergen's...
- The Defense Logistics Agency Troop Support Medical awarded a $2,431.57 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 56 tablets of 1 mg varenicline under contract number 4561501889. The delivery order is to supply pharmaceutical products and has a period of performance from July 14, 2023 through July 17, 2023. Amerisourcebergen Drug Corporation will fulfill the order from its facility located in Conshohocken, Pennsylvania. No subcontractors or set aside designations...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Varenicline 1 mg tablets. The contract has a ceiling value of $3,055.43 and a completion date of April 24, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of 56 tablets of the medication varenicline 0.5 mg, with a potential value of $1,137.16 and a completion date of March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp...
- The Defense Logistics Agency awarded a $4,580 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 56 units of 0.5 mg Varenicline tablets. The tablets will be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 28, 2023 to support the Department of Defense's pharmaceutical needs. As a major pharmaceutical supplier, Amerisourcebergen will deliver the stop smoking aid tablets to DLA under its indefinite-delivery/indefinite-quantity Pharmaceutical...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT3WWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varenicline 0.5 mg tablets (56-count units) under a firm fixed-price contract with a ceiling value of $5,061.75. The award, issued on May 22, 2025, represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of May 23, 2025. This order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal government health systems worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capability in fulfilling federal medical procurement requirements through numerous competitively awarded contracts with the Defense Logistics Agency across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 5/22/25 |